Selected Transaction: Fairness Opinion

The Client

Dynagen, Inc. develops, manufactures and sells generic drugs. The Company's manufacturing subsidiary, Able Laboratories, produces tablets and suppositories. The Company's distribution subsidiaries, GDI and Superior Pharmaceuticals Co., sell and distribute products manufactured by almost all of the major generic drug manufacturers. In addition, they provide sales and marketing support for all of Able's products.

The Assignment

Context Capital Group ("Context Capital") was retained by the board of directors of Dynagen, Inc. to express an opinion on the fairness, from a financial viewpoint, of the sale of its wholly owned subsidiary, Superior Pharmaceuticals Co. to RxBazaar.com, Inc. The board of directors sought an independent opinion for the transaction because of the large group of shareholders with diverse and often conflicting interests.